Versant Capital Management, Inc Zoetis Inc. Transaction History

Versant Capital Management, Inc

$578 Million
Q1 2025

A detailed history of Versant Capital Management, Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 3,095 shares of ZTS stock, worth $489,195. This represents 0.09% of its overall portfolio holdings.

Number of Shares

3,095

Previous 1,114 177.83%

Holding current value

$489,195

Previous $181,000 181.22%

% of portfolio

0.09%

Previous 0.04%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 03, 2025	BUY	$156.48 - $175.67 $309,986 - $348,002	1,981 Added 177.83%	3,095 $509,000
Q4 2024 Jan 02, 2025	BUY	$162.24 - $194.42 $72,845 - $87,294	449 Added 67.52%	1,114 $181,000
Q3 2024 Oct 07, 2024	BUY	$172.58 - $196.48 $22,435 - $25,542	130 Added 24.3%	665 $129,000
Q2 2024 Jul 05, 2024	BUY	$145.54 - $178.83 $63,892 - $78,506	439 Added 457.29%	535 $92,000
Q1 2024 Apr 03, 2024	SELL	$165.67 - $199.94 $828 - $999	-5 Reduced 4.95%	96 $16,000
Q4 2023 Jan 08, 2024	BUY	$151.44 - $200.09 $3,028 - $4,001	20 Added 24.69%	101 $19,000
Q3 2023 Oct 11, 2023	BUY	$167.14 - $192.77 $668 - $771	4 Added 5.19%	81 $14,000
Q2 2023 Jul 10, 2023	BUY	$160.94 - $186.23 $1,609 - $1,862	10 Added 14.93%	77 $13,000
Q1 2023 Apr 10, 2023	BUY	$145.48 - $175.02 $1,163 - $1,400	8 Added 13.56%	67 $11,000
Q4 2022 Jan 25, 2023	SELL	$131.14 - $157.47 $393 - $472	-3 Reduced 4.84%	59 $0
Q1 2022 Apr 29, 2022	SELL	$181.39 - $234.03 $906 - $1,170	-5 Reduced 7.46%	62 $12,000
Q3 2021 Oct 29, 2021	BUY	$189.29 - $209.69 $567 - $629	3 Added 4.69%	67 $13,000
Q2 2021 Jul 22, 2021	SELL	$155.9 - $187.99 $4,521 - $5,451	-29 Reduced 31.18%	64 $12,000
Q4 2020 Feb 08, 2021	BUY	$157.07 - $174.35 $471 - $523	3 Added 3.33%	93 $15,000
Q3 2020 Nov 02, 2020	BUY	$137.1 - $165.37 $548 - $661	4 Added 4.65%	90 $14,000
Q1 2020 Apr 17, 2020	BUY	$92.66 - $144.94 $2,687 - $4,203	29 Added 50.88%	86 $10,000
Q4 2019 Jan 28, 2020	SELL	$116.25 - $133.25 $4,766 - $5,463	-41 Reduced 41.84%	57 $7,000
Q2 2019 Jul 16, 2019	SELL	$97.98 - $114.28 $3,821 - $4,456	-39 Reduced 28.47%	98 $11,000
Q1 2019 Apr 23, 2019	BUY	$81.56 - $100.67 $10,113 - $12,483	124 Added 953.85%	137 $13,000
Q1 2019 Apr 23, 2019	SELL	$81.56 - $100.67 $10,113 - $12,483	-124 Reduced 90.51%	13 $13,000
Q1 2018 Apr 19, 2018	SELL	$71.51 - $84.69 $214 - $254	-3 Reduced 2.14%	137 $11,000
Q4 2017 Apr 19, 2018	SELL	$63.24 - $72.8 $252 - $291	-4 Reduced 2.78%	140 $10,000
Q2 2017 Apr 23, 2018	SELL	N/A	-40 Reduced 21.74%	144 $8,000
Q3 2016 Apr 23, 2018	SELL	N/A	-7 Reduced 3.66%	184 $9,000
Q2 2016 Apr 23, 2018	BUY	N/A	5 Added 2.69%	191 $9,000
Q1 2016 Apr 23, 2018	BUY	N/A	9 Added 5.08%	186 $8,000
Q4 2015 Apr 23, 2018	BUY	N/A	177	177 $8,000

Others Institutions Holding ZTS

# of Institutions

2,093

Shares Held

417M

Call Options Held

1.24M

Put Options Held

1.61M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $74B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.

Account

Versant Capital Management, Inc Zoetis Inc. Transaction History